Registry of Lobbyists

Registration - Consultant

BIOGEN CANADA, INC. / MARTIN CAMPBELL, Consultant

Registration Information

Client name: BIOGEN CANADA, INC.
Lobbyist name: MARTIN CAMPBELL, Consultant
Initial registration start date: 1997-10-01
Registration status: Inactive
Registration Number: 778720-6922

Version 1 of 1 (1997-10-01 to 1998-04-21)

Version 1 of 1 (1997-10-01 to 1998-04-21) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: MARTIN H CAMPBELL    Lobbyist business address
Consulting firm: BEARD, WINTER LLP
900-150 KING STREET WEST
TORONTO, ON  M5H 2K4
Canada
Position: LAWYER
Telephone number: 416-593-5555  
Fax number: 416-593-7760  
 
Former public office holder: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: BIOGEN CANADA, INC.
900 - 150 KING STREET WEST
TORONTO, ON  M5H 2K4
Canada
Telephone number: 416-593-5555
Fax number: 416-593-7760  
 
Client Representative: DAVID KONYS
 
The client is a subsidiary of the following parent companies: BIOGEN
14 CAMBRIDGE CENTER
CAMBRIDGE, MA
United States of America 01242

Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Health Canada (HC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Intellectual Property, Science and Technology
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program (NEW DRUG SUBMISSION) HEALTH PROTECTION BRANCH,




Date Modified: